Literature DB >> 6731444

Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene.

C A Snyder, B D Goldstein, A R Sellakumar, R E Albert.   

Abstract

A group of 40 Sprague-Dawley rats was exposed to 100 ppm benzene for 6 h/day, 5 days/week for life. Another group of 40 rats received air under the same exposure regimen. During the exposures, treated rats exhibited continuously depressed peripheral erythrocyte and lymphocyte counts. Although the incidences of these peripheral cell depressions were statistically significant, the magnitudes of the depressions were not. Histopathologic evaluation revealed that splenic hemosiderin pigments were much more prevalent in exposed rats than in controls, indicating either red cell hemolysis or ineffective erythropoiesis. The mortality-corrected tumor incidences between exposed and control mice were not statistically different. However, several exposed rats died with tumors that, because of their rare spontaneous incidence, are most likely treatment-related. Four rats died with liver tumors, two died with zymbal gland carcinoma, and one died with chronic myelogenous leukemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731444     DOI: 10.1002/ajim.4700050603

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  3 in total

1.  The carcinogenicity of discontinuous inhaled benzene exposures in CD-1 and C57Bl/6 mice.

Authors:  C A Snyder; A R Sellakumar; D J James; R E Albert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

2.  Hematotoxicity and carcinogenicity of inhaled benzene.

Authors:  E P Cronkite; R T Drew; T Inoue; Y Hirabayashi; J E Bullis
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

Review 3.  Benzene toxicity and risk assessment, 1972-1992: implications for future regulation.

Authors:  D J Paustenbach; R D Bass; P Price
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.